Literature DB >> 16078967

Procalcitonin and infection in elderly patients.

Fabien Stucker1, François Herrmann, Jean-Daniel Graf, Jean-Pierre Michel, Karl Heinz Krause, Gaëtan Gavazzi.   

Abstract

OBJECTIVES: To compare the usefulness of procalcitonin (PCT) in detecting infection in elderly patients with that of other clinical and biological markers.
DESIGN: Prospective observational study to compare PCT levels in infected and uninfected patients.
SETTING: Geriatric teaching hospital in Switzerland. PARTICIPANTS: Two hundred eighteen elderly patients aged 75 and older admitted to an acute geriatric care unit. MEASUREMENTS: Demographic characteristics, comorbidities, Charlson index, general signs (respiratory rate, temperature, pulse rate, confusion, falls, shivering), presence of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, septic shock, functional score (Functional Independence Measurement (FIM)) biological parameters (PCT, C-reactive protein (CRP), leukocytes, albumin), and definite diagnosis at admission were collected prospectively for each patient.
RESULTS: Long-term corticotherapy, chronic immune diseases, fever of 38 degrees C or higher, white blood cell count, pulse rate, FIM, SIRS, sepsis, CRP of 3 mg/mL or higher, and PCT of 0.5 ng/mL or higher were associated with an infection at admission. In multivariate analysis, only sepsis and CRP of 3 mg/mL or higher were still associated with an infection; PCT levels do not show any significant association in the multivariate analysis. In addition, when PCT had good specificity (94%), it had low sensitivity (24%). False-negative PCT was related to lower severity of infection (lower inflammatory reaction and lower acute renal failure) than true-positive PCT. This finding may also be related to aging per se.
CONCLUSION: PCT may be useful to identify severely ill elderly patients admitted to an acute geriatric ward but not to discriminate patients with infection from those without.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078967     DOI: 10.1111/j.1532-5415.2005.53421.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  23 in total

Review 1.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

2.  Outpatient Antibiotic Prescription.

Authors:  Jörg Bätzing-Feigenbaum; Maike Schulz; Mandy Schulz; Ramona Hering; Winfried V Kern
Journal:  Dtsch Arztebl Int       Date:  2016-07-01       Impact factor: 5.594

Review 3.  Diagnostic challenges and opportunities in older adults with infectious diseases.

Authors:  David van Duin
Journal:  Clin Infect Dis       Date:  2011-12-20       Impact factor: 9.079

4.  Infections in the older population: what do we know?

Authors:  Didier Schoevaerdts; François-Xavier Sibille; Gaetan Gavazzi
Journal:  Aging Clin Exp Res       Date:  2019-10-26       Impact factor: 3.636

Review 5.  Prosthetic joint infections in the elderly.

Authors:  G De Angelis; N T Mutters; L Minkley; F Holderried; E Tacconelli
Journal:  Infection       Date:  2015-06-22       Impact factor: 3.553

6.  Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery.

Authors:  Christian P Schneider; Martin K Angele; Wolfgang H Hartl
Journal:  Crit Care       Date:  2010-01-21       Impact factor: 9.097

7.  Diagnostic value of procalcitonin in acutely hospitalized elderly patients.

Authors:  O Steichen; E Bouvard; G Grateau; S Bailleul; J Capeau; G Lefèvre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-01       Impact factor: 3.267

8.  The pattern of procalcitonin in primary total hip and knee arthroplasty and its implication in periprosthetic infection.

Authors:  Syed Ali; Andrew Christie; Andrew Chapel
Journal:  J Clin Med Res       Date:  2009-05-20

9.  The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID-19 Pneumonia.

Authors:  Andrea Ticinesi; Antonio Nouvenne; Beatrice Prati; Loredana Guida; Alberto Parise; Nicoletta Cerundolo; Chiara Bonaguri; Rosalia Aloe; Angela Guerra; Tiziana Meschi
Journal:  Mediators Inflamm       Date:  2021-06-28       Impact factor: 4.711

10.  Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia.

Authors:  Ji Hye Kim; Joo Wan Seo; Jeong Ha Mok; Mi Hyun Kim; Woo Hyun Cho; Kwangha Lee; Ki Uk Kim; Doosoo Jeon; Hye-Kyung Park; Yun Seong Kim; Hyung Hoi Kim; Min Ki Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.